z-logo
open-access-imgOpen Access
An integrin-activating peptide, PHSRN, ameliorates inhibitory effects of conventional peritoneal dialysis fluids on peritoneal wound healing
Author(s) -
Tetsu Miyamoto,
Masaru Tamura,
Narutoshi Kabashima,
Ryota Serino,
Tatsuya Shibata,
Y. Furuno,
M. Miyazaki,
Ryoko Baba,
N. Sato,
Yoshiaki Doi,
Masahiro Okazaki,
Yutaka Otsuji
Publication year - 2009
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfp601
Subject(s) - peritoneal dialysis , medicine , mesothelial cell , wound healing , motility , fibronectin , peritoneal cavity , pathology , microbiology and biotechnology , cell , chemistry , biochemistry , surgery , biology
Bioincompatible peritoneal dialysis fluids (PDFs) cause pathological changes in the peritoneal membrane, related to membrane dysfunction and progressive peritoneal fibrosis. We investigated the effects of Pro-His-Ser-Arg-Asn (PHSRN) peptide, one of the fibronectin cell-binding domains that activates integrins and reinforces wound healing, on peritoneal remodelling in a rat peritoneal injury model undergoing peritoneal dialysis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom